Clinical Trials

45 enrolled

Uterine Cervical Neoplasms, Renal Insufficiency

NCT06263062 2024-02-16

Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study

60 enrolled

Pathophobia, Uterine Cervical Neoplasms

NCT06261892 2024-02-15

Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine

300 enrolled

Uterine Cervical Neoplasms

NCT02820506 2024-02-08

SENTIREC II

300 enrolled

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT06069648 2024-02-07

Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening

270 enrolled

Uterine Cervical Neoplasms

NCT05189028 2024-02-06

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

Phase 3 Unknown

290 enrolled

Uterine Cervical Neoplasms

NCT06223308 2024-01-25

A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors

Phase 1/2 Unknown

54 enrolled

Uterine Cervical Neoplasms

NCT05084677 2024-01-18

Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

96 enrolled

Uterine Cervical Neoplasms

NCT04683549 2024-01-08

HPV-RICCO

Uterine Cervical Neoplasms

NCT04903561 2023-11-24

BELGSSAR

1,200 enrolled

Uterine Cervical Neoplasms

NCT05588219 2023-11-24

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms

NCT05048407 2023-11-18

Sirius in Gynaecological Laparoscopic Surgery

Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT06136702 2023-11-18

ELEVATE AS

1,048 enrolled

Uterine Cervical Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT00997009 2023-11-14

MITO CERV 2

108 enrolled

Uterine Cervical Neoplasms

NCT03750539 2023-11-14

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

100 enrolled

Uterine Cervical Neoplasms

NCT04070976 2023-11-14

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer

82 enrolled

Uterine Cervical Neoplasms

NCT02584478 2023-11-08

AL3818

Phase 3 Unknown

294 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05125380 2023-11-03

Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia

1,200 enrolled

Uterine Cervical Neoplasms, Sexually Transmitted Diseases

NCT04670445 2023-10-23

UPLIFT

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

210 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Melanoma, Mesothelioma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms

NCT06095674 2023-10-23

ITHACA

Uterine Cervical Neoplasms

NCT06095882 2023-10-23

Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery After Radical Cervical Cancer Surgery

180 enrolled

Uterine Cervical Neoplasms

NCT03876860 2023-10-05

An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis

118 enrolled

Uterine Cervical Neoplasms, Radiation Injuries, Endometrial Neoplasms

NCT06015360 2023-10-05

GRASS

8 enrolled

Uterine Cervical Neoplasms

NCT05420545 2023-08-18

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

36 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05468190 2023-08-18

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

48 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05318625 2023-08-03

A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.

Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT05690906 2023-07-06

Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer

100 enrolled

Uterine Cervical Neoplasms

NCT05902390 2023-06-15

The Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therapy.

106 enrolled

Uterine Cervical Neoplasms

NCT05895370 2023-06-08

GI-HPVT-01

12 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT05881902 2023-05-31

THE EFFECT OF CANCER EDUCATION ON WOMEN'S AWARENESS LEVELS AND THEIR BEHAVIORS ON SCREENINGS

60 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Neoplasms

NCT05606263 2023-05-26

GCR-05

55 enrolled

Uterine Cervical Neoplasms

NCT03726151 2023-05-10

Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs

17,000 enrolled

Phase EARLY_PHASE1 Unknown

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05812677 2023-04-14

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

20 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05393440 2023-04-07

CC-OV01

18 enrolled

Uterine Cervical Neoplasms

NCT04689178 2023-02-06

IMPACTGP

195,000 enrolled

Uterine Cervical Neoplasms

NCT05669872 2023-01-05

Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

334 enrolled

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05446883 2022-11-30

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Phase 3 Unknown

498 enrolled

Uterine Cervical Neoplasms

NCT05561413 2022-10-03

GEMS

40 enrolled

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05557565 2022-09-28

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

150 enrolled

Uterine Cervical Neoplasms

NCT03634982 2022-09-01

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

133 enrolled

Urinary Bladder Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Noonan Syndrome, Ovarian Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Skin Neoplasms, Thoracic Neoplasms, Uterine Neoplasms, Neoplasms, Squamous Cell

NCT04641728 2022-08-09

Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

28 enrolled

Uterine Cervical Neoplasms

NCT05179317 2022-07-29

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

60 enrolled

Uterine Cervical Neoplasms

NCT05475847 2022-07-28

TIL

20 enrolled

Uterine Cervical Neoplasms

NCT05247619 2022-07-15

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

49 enrolled

Uterine Cervical Neoplasms

NCT05444374 2022-07-05

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

48 enrolled

Uterine Cervical Neoplasms

NCT03827837 2022-07-01

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

265 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05122221 2022-06-28

CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers